On the 8th of April 2021, Professor Eva Hoffmann was among the first presenters at the virtual ’Best of ASRM & ESHRE 2021’ conference with her lecture on Molecular mechanisms behind women’s...
In the opinion piece in Politiken, the authors Søren Ziebe, Lone Schmidt and Sophie Hæstorp Andersen bring up a sensitive, yet necessary topic, namely how reproductive challenges also impact our welfare model.
In February 2021 Henriette Svarre Nielsen stepped into ReproUnion’s Executive Board. Since 2018 she has been part of ReproUnion’s Challenge 2 and worked alongside colleagues in Greater Copenhagen to launch the ReproUnion Biobank & Infertility Cohort (RUBIC).
EU/Interreg, Region Hovedstaden, Region Skåne and Ferring are supporting ReproUnion with EUR 2.3 million to carry out additional reproductive research, which will assess the impact of the COVID-19 virus on fertility, pregnancy, and fetus.
Fostering the next generation of researchers is vital to meet the future demands of managing and preventing infertility problems. Here we feature Selma Kløve Landersø and Pernille Udesen, who were among the first to virtually defend their ReproUnion supported-PhDs during the COVID-19 pandemic.
As part of ReproUnion in 2018, Gritt Marie Hviid Malling initiated a study, which was published in Human Fertility in March 2020. The findings are presented at ReproUnion's Fertility Awareness...
The first week of November marked the European Fertility week 2020, calling for European policymakers to ensure equal, fair and safe access to fertility treatments.
The new resources from the ReproUnion Biobank & Infertility Cohort (RUBIC) will enhance the dialogue with couples interested in the research project.
In his final State of the Union Address in 2016, President Obama called on then Vice President Biden to lead a new, national “Moonshot” initiative to eliminate cancer as we know it. The European Cancer Moonshot Lund Center was established and ReproUnion board member, Professor Johan Malm, had the pleasure to meet Joe Biden.
“We need deeper insights about the biology associated with ovarian ageing to provide future strategies for prevention and/or treatments of age-related female infertility. Ultimately, a clinical biomarker for ovarian ageing would enable women to better plan the time for pregnancy – according to their own life preferences in combination with their own biology,” said Kristina Wendelboe Olsen, who defended her PhD on th25 September 2020.